| Biomarker ID | 407 |
| PMID | 19117982 |
| Year | 2009 |
| Biomarker | Androgen Receptor AR-V1 |
| Biomarker Basis | Expression Based |
| Biomolecule | mRNA |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Upregulated in Hormone Refactory Prostate Cancer (22 fold) |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways Include:-Prostate cancer,Androgen receptor signaling, proteolysis, and transcription regulation,SMAD2/3 nuclear pathway,Oocyte meiosis,SIDS susceptibility pathways |
| Experiment | Hormone Naive Vs Hormone Refractory Prostate Cancer |
| Type of Biomarker | Prognostic |
| Cohort | 83 patients diagnosed with Hormone-naive prostate cancer were chosen, along with 25 patients diagnosed with Hormone-Refractory prostate cancer. |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.0001 |
| Method Used | qRT-PCR |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | AR |